Peer-reviewed articles

Vener C, Rossi S, Minicozzi P, et al. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials. Front Oncol. 2022;12:892684. doi:10.3389/fonc.2022.892684

Ssenyonga N, Stiller C, Nakata K, et al. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. The Lancet Child & Adolescent Health. 2022;6(6):409-431. doi:10.1016/S2352-4642(22)00095-5

Sexton GP, Walsh P, Moriarty F, O’Neill JP. The changing face of Irish head and neck cancer epidemiology: 20 years of data. Eur Arch Otorhinolaryngol. 2022;279(6):3079-3088. doi:10.1007/s00405-021-07118-4

Menzies S, O’Leary E, Callaghan G, et al. A population-based comparison of organ transplant recipients in whom cutaneous squamous cell develops versus those in whom basal cell carcinoma develops. J Am Acad Dermatol. 2022;86(6):1377-1379. doi:10.1016/j.jaad.2021.05.032

Anderson S, Breen KJ, Davis NF, Deady S, Sweeney P. Penile cancer in Ireland - A national review. Surgeon. 2022;20(3):187-193. doi:10.1016/j.surge.2021.04.004

Kelly M, O’Brien KM, Hannigan A. Specialist palliative cancer care in acute hospitals and place of death: a population study. BMJ Support Palliat Care. 2022;12(e1):e94-e102. doi:10.1136/bmjspcare-2020-002232

O’Connell E, McDevitt J, Hill ADK, McNamara DA, Burke JP. Centralisation of rectal cancer care has improved patient survival in the republic of Ireland. Eur J Surg Oncol. 2022;48(4):890-895. doi:10.1016/j.ejso.2021.10.031

Araghi M, Fidler-Benaoudia M, Arnold M, et al. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study. Thorax. 2022;77(4):378-390. doi:10.1136/thoraxjnl-2020-216555

Molcho M, Thomas AA, Walsh PM, Skinner R, Sharp L. Social inequalities in treatment receipt for childhood cancers in Ireland: A population-based analysis. Int J Cancer. 2022;150(6):941-951. doi:10.1002/ijc.33856

Keeling E, O’Leary E, Deady S, O Neill JP, Conlon PJ, Moloney FJ. Gender and immunosuppression impact on Merkel cell carcinoma diagnosis and prognosis. A population based cohort study. Skin Health Dis. 2022;2(1):e80. doi:10.1002/ski2.80

Andersson TML, Rutherford MJ, Myklebust TÅ, et al. A way to explore the existence of “immortals” in cancer registry data – An illustration using data from ICBP SURVMARK-2. Cancer Epidemiology. 2022;76:102085. doi:10.1016/j.canep.2021.102085

Clarke N, Dunne S, Coffey L, et al. Health literacy impacts self-management, quality of life and fear of recurrence in head and neck cancer survivors. J Cancer Surviv. 2021;15(6):855-865. doi:10.1007/s11764-020-00978-5

Rosato V, Gómez-Rubio P, Molina-Montes E, et al. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study. Eur J Cancer Prev. 2021;30(6):423-430. doi:10.1097/CEJ.0000000000000588

Girardi F, Rous B, Stiller CA, et al. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro-Oncology. 2021;23(10):1765-1776. doi:10.1093/neuonc/noab067

Morgan E, Arnold M, Rutherford MJ, et al. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project). Int J Cancer. 2021;149(5):1013-1020. doi:10.1002/ijc.33620

O’Connor M, Céilleachair AÓ, O’Brien K, et al. Health-related quality of life in women after colposcopy: results from a longitudinal patient survey. Qual Life Res. 2021;30(9):2509-2520. doi:10.1007/s11136-021-02831-3

Prior L, O’Dwyer R, Farooq AR, et al. Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study. Breast Cancer Res Treat. 2021;189(1):269-283. doi:10.1007/s10549-021-06263-y

Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002-1013. doi:10.1016/S1470-2045(21)00199-6

Sacchetto L, Rosso S, Comber H, et al. Skin melanoma deaths within 1 or 3 years from diagnosis in Europe. Intl Journal of Cancer. 2021;148(12):2898-2905. doi:10.1002/ijc.33479

Pilleron S, Charvat H, Araghi M, et al. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. Int J Cancer. 2021;148(7):1575-1585. doi:10.1002/ijc.33326

Andersson TML, Myklebust TÅ, Rutherford MJ, et al. The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study. Cancer Epidemiol. 2021;71(Pt A):101881. doi:10.1016/j.canep.2020.101881

Andersson TML, Rutherford MJ, Myklebust TÅ, et al. Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study. Br J Cancer. 2021;124(5):1026-1032. doi:10.1038/s41416-020-01196-7

López de Maturana E, Rodríguez JA, Alonso L, et al. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Genome Med. 2021;13(1):15. doi:10.1186/s13073-020-00816-4

Morgan E, Soerjomataram I, Gavin AT, et al. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 2021;70(2):234-242. doi:10.1136/gutjnl-2020-321089

Molina-Montes E, Coscia C, Gómez-Rubio P, et al. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. Gut. 2021;70(2):319-329. doi:10.1136/gutjnl-2019-319990